Elvia Cowan

Insider Reports History

Entity
Individual
Location
C/O Vaxcyte, Inc., 825 Industrial Road, Suite 300, San Carlos, CA
Signature
Elvia Cowan, by /s/ Peter N. Efremenko, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elvia Cowan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vaxcyte, Inc. SVP, FINANCE Common Stock 24.1K $1.74M $72.10 Mar 3, 2025 Direct
Vaxcyte, Inc. SVP, FINANCE Stock Option (right to buy) 18K Feb 27, 2025 Direct
Vaxcyte, Inc. SVP, FINANCE Performance Stock Option (right to buy) 11.9K Nov 7, 2024 Direct

Insider Reports Filed by Elvia Cowan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PCVX Vaxcyte, Inc. Feb 27, 2025 4 -$41.1K 4 Mar 3, 2025 SVP, FINANCE
PCVX Vaxcyte, Inc. Dec 16, 2024 2 $200K 4 Dec 18, 2024 SVP, FINANCE
PCVX Vaxcyte, Inc. Nov 7, 2024 1 $0 4 Nov 8, 2024 SVP, FINANCE
PCVX Vaxcyte, Inc. Sep 3, 2024 4 -$535K 4 Sep 5, 2024 SVP, FINANCE
PCVX Vaxcyte, Inc. Jul 16, 2024 3 -$295K 4 Jul 17, 2024 SVP, FINANCE
PCVX Vaxcyte, Inc. Jul 8, 2024 3 -$270K 4 Jul 9, 2024 SVP, FINANCE
PCVX Vaxcyte, Inc. Feb 29, 2024 8 -$603K 4 Mar 4, 2024 SVP, FINANCE
PCVX Vaxcyte, Inc. Sep 5, 2023 1 -$32K 4 Sep 6, 2023 SVP, Finance
PCVX Vaxcyte, Inc. Mar 1, 2023 2 $0 4 Mar 3, 2023 SVP, Finance
PCVX Vaxcyte, Inc. Jan 1, 2023 0 $0 3 Jan 4, 2023 SVP, Finance and Principal Accounting Officer